@article{60c2ddc81e8247e695132f6eb5f4ac97,
title = "Lessons from the amblyopia treatment studies",
author = "Repka, \{Michael X.\} and Holmes, \{Jonathan M.\}",
note = "Funding Information: Financial Disclosure(s): Supported by the National Eye Institute of the National Institutes of Health, Department of Health and Human Services EY011751 and EY018810 and Research to Prevent Blindness, Inc. New York, NY (J.M.H. as Olga Keith Weiss Scholar and unrestricted grants to the Department of Ophthalmology, Mayo Clinic , and Wilmer Eye Institute, Johns Hopkins University ). Funding Information: The Pediatric Eye Disease Investigator Group (PEDIG) was established in 1997 to provide a structure for conducting clinical trials in pediatric eye disease as part of clinical practice. 1 Success of the network has been the product of the enthusiastic participation of pediatric eye care providers across the United States and Canada, as well as funding from the National Eye Institute. A major area of focus has been the management of children and adolescents with amblyopia caused by strabismus, anisometropia or both combined, which comprise the overwhelming majority of patients with amblyopia. While an extensive literature existed on the subject of amblyopia therapy, much was retrospective and nonrandomized, and so before 2000, the management of amblyopia was largely based on consensus guidelines. ",
year = "2012",
month = apr,
doi = "10.1016/j.ophtha.2011.12.003",
language = "English (US)",
volume = "119",
pages = "657--658",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "4",
}